Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEAMM
ISRCTN51731976Phase 3Completed
- Sponsor
- University of Birmingham
- Start
- Apr 2012
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in multiple myeloma (MM) comparing Levofloxacin prophylaxis with Placebo (2 arms). Primary endpoint: Number of febrile episodes. Started Apr 2012; status: completed.
02
Drugs
levofloxacin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on ISRCTN51731976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN51731976.